MYLAN INC.
DelistedCIK 69499fmd_0DAF8V287G5CJ52C8YNMTMXWEVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Dec 31, 2014, 25 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|---|
| Total revenues | 5,138 | 5,093 | 5,451 | 6,130 | 6,796 | 6,909 | 7,720 |
| Cost of revenue | 3,067 | 3,018 | 3,233 | 3,566 | 3,888 | 3,869 | 4,192 |
| Gross profit | 2,070 | 2,074 | 2,217 | 2,563 | 2,908 | 3,040 | 3,528 |
| Research and development | 317 | 275 | 282 | 295 | 401 | 508 | 582 |
| Selling, general and administrative | 1,053 | 1,050 | 1,087 | 1,215 | 1,392 | 1,409 | 1,626 |
| Total operating expenses | 1,772 | 1,551 | 1,496 | 1,558 | 1,799 | 1,905 | 2,175 |
| Operating income | 298 | 523 | 722 | 1,005 | 1,109 | 1,136 | 1,353 |
| Interest expense | 381 | 318 | 331 | 336 | 309 | 313 | 333 |
| Other non-operating income (expense) | 11 | 22 | (34) | (15) | 4 | (75) | (45) |
| Income before taxes | (72) | 227 | 356 | 655 | 804 | 747 | 975 |
| Income tax expense | 129 | (21) | 10 | 116 | 161 | 121 | 41 |
| Net income from continuing operations | (200) | 248 | 346 | 539 | 643 | 627 | 933 |
| Net income | (196) | 233 | 345 | 537 | 641 | 627 | 933 |
| Net income to common shareholders | (335) | 94 | 224 | 537 | 641 | 624 | 929 |